Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021

JAMA. 2021 Oct 12;326(14):1436-1438. doi: 10.1001/jama.2021.15265.

Abstract

This study examines the prevalence of SARS-CoV-2 antibodies among blood donors aged 16 to 64 years in Kenya from January to March 2021.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Blood Donors*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 Serological Testing
  • Female
  • Humans
  • Kenya
  • Male
  • Middle Aged
  • Prevalence
  • SARS-CoV-2 / immunology*
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Antibodies, Viral